3'-Galactosyllactose (3'GL) has excellent biological activities, such as anti-inflammatory, regulating the immune system and the balance of intestinal flora. It has shown potential and broad market prospects in the infant formula industry and the medical industry. Through competent assistance by our researchers and the fastest delivery of high-quality 3'GL products at fair prices, CD BioGlyco has become a "preferred supplier" of many clients.
Human milk oligosaccharides (HMOs) are low-polymer sugars that cannot be digested by the gastrointestinal tract but can be hydrolyzed by colonized microorganisms in the intestinal tract. They produce small molecular organic acids, nourish intestinal epithelial cells, maintain the intestinal mucosal barrier, and resist the invasion of pathogenic microorganisms while reducing the pH value of the colon and promoting the absorption of calcium, magnesium, iron, and other minerals. Some functional HMO structures with elevated expression levels in mammalian colostrum form different galactosyl-lactoses based on the extension of lactose, such as 3'GL (beta-D-Galp-(1-3)-beta-D-Galp-(1-4)-D-Glc). The development of science and technology and the exploration of scientific researchers led to the discovery of the structure and some functions of 3'GL, which are expected to be applied to human food and medicine.
Fig.1 Six simple oligosaccharide structures including 3'GL. (Zuurveld, et al., 2020)
Although 3'GL has been isolated from bovine colostrum before, it was isolated from human milk glycan for the first time through cycle chromatography by Donald and Feeney in 1988. Later, it is separated from bear, camel, reindeer, elephant, and other mammals' milk. As a special oligosaccharide structure in breast milk, 3'GL has many beneficial and positive effects on infant health, such as regulating innate immunity and cultivating healthy intestinal microflora. Recently, some studies have shown that 3'GL may attenuate NF-kB inflammatory signaling, which has an anti-inflammatory effect on human intestinal epithelial cells in vitro. 3'GL has potential clinical research value as a strong physiological anti-inflammatory agent in human colostrum and early milk.
CD BioGlyco has accumulated a variety of Production Solutions to meet changing client needs, including but not limited to the following technologies:
Various high-grade standards and fully optimized separation routes.
Selection and identification of suitable enzymes, such as galactosidase.
Optimal enzyme expression levels.
A complete and mature service product line from strain development to mass manufacturing.
Including protein engineering, metabolic engineering, and synthetic biology strategies and tools.
CD BioGlyco offers a comprehensive range of 3′GL production services tailored to the unique needs of the industry. We provide both chemical and enzymatic synthesis options, allowing for flexibility in scale and purity.
Our services include:

DOI: 10.3390/nu13093190
Journal: Nutrients
IF: 5.0
Published: 2021
Results: This study investigates how trans-galacto-oligosaccharides (TOS), a mixture rich in the 3′GL, mitigate the immunotoxic and intestinal-damaging effects of deoxynivalenol (DON)—a common cereal-contaminating mycotoxin—through preclinical in vivo (murine) and in vitro (Caco-2 cell) experiments. The study concludes TOS, via 3′GL, counteracts DON toxicity by restoring Th1-mediated immunity, preserving intestinal integrity, and supporting gut microbiota, highlighting its potential as a functional food supplement.
Scalability
We are equipped to produce 3′GL at scales ranging from milligrams to kilograms, seamlessly supporting your project from initial research to commercialization.
Unmatched purity
Our stringent quality control measures ensure a product with exceptional purity, critical for sensitive applications in nutrition and medicine.
Accelerated timelines
Our optimized workflow and expert team ensure that your project is completed efficiently, helping you get your products to market faster.
Functional Foods & Beverages
Incorporation of 3′GL into foods and beverages offers a natural and effective way to promote digestive and immune health for a broad consumer base.
Pharmaceuticals & Nutraceuticals
The immunomodulatory properties of 3′GL open new avenues for drug development, dietary supplements, and therapeutic applications aimed at enhancing immune function and gut health.
Cosmetics
Emerging research suggests potential applications for 3′GL in skincare products due to its moisturizing and prebiotic properties.
"CD BioGlyco provided exceptional service for our 3′GL project. Their team was highly knowledgeable and helped us navigate the complexities of scaling up production. The product was of superior purity, and their detailed report was invaluable for our downstream analysis. The entire process was seamless and on time."
- Dr. A., Head of Pharmaceutical R&D
"Working with CD BioGlyco was a fantastic experience. Their team was very responsive and guided us through the entire process, from selecting the right synthesis method to ensuring the final product met all our specifications. Their expertise truly made a difference in the success of our project."
- Dr. J., Lead Scientist, Glycomics Research
"The quality and consistency of the 3′GL product we received from CD BioGlyco were outstanding. It allowed us to focus on our research without worrying about the raw material. The technical support provided was excellent, and we look forward to future collaborations."
- Dr. M., Director of Formulation
With rich production experience of oligosaccharides, CD BioGlyco provides you with high-quality services for 3'GL production. If you are interested in our services, please contact us feel free.
References